Novavax faces high stakes FDA review this week that will decide the fate of its Covid vaccine in the U.S.CNBC • 06/06/22
Novavax's stock slides 23% after FDA details myocarditis cases for COVID-19 vaccine candidateMarket Watch • 06/03/22
Novavax Covid-19 Vaccine Linked to Heart Inflammation, FDA Says. The Stock Is Sliding.Barrons • 06/03/22
The FDA May Decide on Novavax's Vaccine Next Week: Here's What You Need to KnowThe Motley Fool • 06/02/22
Novavax Gets First Sell Rating Since 2020. It's Got a Covid Vaccine Problem, Analyst Says.Barrons • 05/20/22
4 Growth Stocks Billionaire Money Managers Piled Into During the First QuarterThe Motley Fool • 05/19/22